Related Experiment Videos
Racial differentials in the identification of hypercholesterolemia
E H Naumburg1, P Franks, B Bell
1Department of Family Medicine, University of Rochester, New York.
The Journal of Family Practice
|April 1, 1993
Summary
Racial minorities are less likely to be screened for high cholesterol and diagnosed with hypercholesterolemia compared to white Americans. This suggests disparities in healthcare provider behavior influence cardiovascular risk management.
Area of Science:
- Cardiovascular Disease Epidemiology
- Health Disparities Research
- Clinical Practice Analysis
Background:
- African Americans experience higher cardiovascular disease (CVD) rates than white Americans.
- Identifying barriers to CVD risk reduction is crucial for addressing racial disparities.
- This study investigates race-based differences in hypercholesterolemia screening and diagnosis.
Purpose of the Study:
- To examine the association between patient race and the likelihood of receiving cholesterol screening.
- To determine if race influences the diagnosis of hypercholesterolemia among screened patients.
- To identify potential provider behavior variations contributing to CVD risk management disparities.
Main Methods:
- Prospective data collection from a family medicine residency program (N=4256).
- Multivariate analyses controlled for age, sex, insurance, socioeconomic status, visit frequency, and other CVD risk factors.
- Inclusion criteria: complete data on demographics and cardiovascular risk factors.
Main Results:
- Minorities were less likely than whites to be screened for cholesterol (adjusted odds ratio [AOR] = 0.84).
- No significant difference in mean cholesterol levels was observed between racial groups.
- Screened minorities were less likely to be diagnosed with hypercholesterolemia than whites (AOR = 0.62), particularly those with high cholesterol levels (AOR = 0.47).
Conclusions:
- Provider behavior in diagnosing hypercholesterolemia appears to vary significantly by patient race.
- These findings highlight potential racial biases in clinical decision-making impacting CVD risk management.
- Further research is needed to address these disparities and improve equitable cardiovascular care.